article thumbnail

Florida woman jailed for lying to FDA about children's drugs trial

Outsourcing Pharma

A Florida doctor has been sent to prison after submitting a false affidavit claiming she had screened children in a clinical study looking at the effectiveness of drugs given to children with asthma when she had not.

article thumbnail

Scepticism in press over Kintor’s COVID-19 US drug trial

pharmaphorum

But Reuters reported that the doctor identified as its principal clinical trial investigator has said he is not in charge of the trial. The post Scepticism in press over Kintor’s COVID-19 US drug trial appeared first on.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

HCP’s use of social media: the good and the not so good

World of DTC Marketing

The best approach is to use social media to connect HCPs to clincial information and drug trials. Doximity was flagged for having anti-vaccine information. HCPs don’t necessarily want pharma trying to sell products via social media.

Nurses 294
article thumbnail

The medical school trying to become anti-racist

The Pharma Data

A major British medical school is leading the drive to eliminate what it calls “inherent racism” in the way doctors are trained in the UK. Exploring the fact that drug trials predominantly involve white, male participants, and looking at how this may lead to inaccurate and harmful prescribing for other patients.

Doctors 52
article thumbnail

Steps to building a more patient-centric industry

pharmaphorum

According to the FDA’s 2020 Drug Trials Snapshot Report , only 8% of clinical trial participants are Black or African American, as compared to nearly 14% of the US population. The fact is, many minorities never learn about vital clinical trials in play, or that they’re eligible to participate.

article thumbnail

Personalising whole genome sequencing doubles diagnosis of rare diseases 

Drug Discovery World

To do so, they tested how using a genomic medicine team of specialist doctors, bioinformaticians, and scientists could boost the capabilities of NHS diagnostic laboratories beyond the standard semi-automated analysis of data. . It can also permit targeted screening of known disease complications and access to drug studies.

Genome 52
article thumbnail

Fatty liver disease: With little early detection, more challenging drug development

pharmaphorum

That was until my doctors stunned me with the news that I had cirrhosis caused by non-alcoholic steatohepatitis, or NASH, a severe form of fatty liver disease that often has few or no symptoms until very late stages. For most of my adult life, I had been the typical American fat guy, gaining a pound or two a year and thinking little of it.